Protein therapeutics delivers proteins to the body in precise amounts (as required by the patient), to treat various medical conditions like diabetes, anemia, chronic renal failure or remake structures. Therapeutic proteins are fast-acting and potent medicines and have proved very successful in the treatment of a wide range of diseases. With growing understanding of the molecular mechanisms of disease, there will continue to be opportunities to develop protein therapeutics. The protein therapeutics field has developed significantly from 1982, since the introduction of the first human insulin protein derived from recombinant DNA. Proteins have several advantages over small molecule drugs that currently dominate the pharmaceutical market.

Increasing focus on development of protein therapeutic products, continuous innovations in recombinant protein drugs, and growing antibody based drugs have led to increased research on protein engineering. Therapeutic proteins and peptides have also been identified as great potential for the treatment of various diseases like cancers, neurodegenerative disease and others. However, physiochemical instability of protein and immunogenicity concerns are likely to restrain the global Protein Therapeutics market over the forecast period.

The "Global Protein Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application, end user and geography. The global Protein Therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Protein Therapeutics market players and offers key trends and opportunities in the market.

The global protein therapeutics market is segmented on the basis of product, application, end user. Based on product, the market is segmented into monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone. The protein therapeutics market by application is categorized into metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others. Based on end user, the protein therapeutics market is classified into pharmaceutical companies, healthcare service providers, research organizations & academic research institutes.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global protein therapeutics market based product, application, and end user. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Protein Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America held the dominant share in protein therapeutics market in 2020. The major share is attributed to technological advancements, favorable reimbursement policies, development of novel products and improved standard of living have led to increased life expectancy, contributing to rise in geriatric population. These factors are boosting growth of protein therapeutics in this region.
The Asia-Pacific region is expected to exhibit highest CAGR during the forecast period due to high prevalence of chronic diseases like diabetes. Also, the growing medical tourism industry in Asia Pacific region is also a major factor that is anticipated to propel the market demand for protein therapeutics market during the forecast period. Moreover, factors like growing demand for advanced treatment options, emerging economies like China, India and Japan, and increasing per capita income are anticipated to create growth avenues for the market players in Asia Pacific over the forecast period.

The report analyzes factors affecting Protein Therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Protein Therapeutics market in these regions.

The report also includes the profiles of key Protein Therapeutics companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the Protein Therapeutics market include Novo Nordisk A/S, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Amgen Inc., AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Inc., and F. Hoffmann-La Roche Ltd among others.

.